amoxicillin has been researched along with Community Acquired Infection in 136 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 26 (19.12) | 18.2507 |
| 2000's | 52 (38.24) | 29.6817 |
| 2010's | 39 (28.68) | 24.3611 |
| 2020's | 19 (13.97) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Barbieri, E; Cantarutti, A; Da Dalt, L; Doná, D; Giaquinto, C; Martinolli, F; Rossin, S | 1 |
| Alcock, AE; Barratt, S; Bielicki, JA; Dunn, D; Faust, SN; Finn, A; Gibb, DM; Hall, D; Hawcutt, DB; Lyttle, MD; Malhotra-Kumar, S; Naufal, N; Powell, C; Robinson, G; Rodriguez-Ruiz, JP; Roland, D; Sharland, M; Stöhr, W; Sturgeon, K | 1 |
| Barry, HC | 1 |
| Barberán, J; Cantón, R; González Del Castillo, J; Linares, M; Molero, JM; Rodríguez-González-Moro, JM; Salavert, M | 1 |
| Ginsburg, AS; May, S | 1 |
| Bielicki, JA; Sharland, M | 1 |
| Park, BL; Trehan, I | 1 |
| Andersen, CT; Garba, S; Grais, RF; Hanson, KE; Isanaka, S; Langendorf, C; Mambula, C; Mouniaman, I; Sayinzonga-Makombe, N | 1 |
| Byrnes, CA; Chang, AB; de Bruyne, J; Elogius, BW; Fong, SM; Grimwood, K; Lawrence, KA; Lee, B; McCallum, GB; Morris, PS; Nachiappan, N; Nathan, AM; Oguoma, VM; Ooi, MH; Saari, N; Torzillo, PJ; Upham, JW; Ware, RS; Yeo, TW; Yerkovich, ST | 1 |
| Slawson, DC | 1 |
| Cohen, HA; Cohen, M; Gerstein, M; Jacobson, E; Loewenberg Weisband, Y; Machnes, MD; Richenberg, Y; Shkalim Zemer, V | 1 |
| A Cruz, S; C Mari, P; F Baroni, I; H Padrao, EM; M F Sanchez, L; Oommen, C; P Calvi, I; R Marques, I | 1 |
| Bach Le, HT; Bach Nguyen, YT; Minh Nguyen, C; Ngoc Bui, HT; Ngoc Phan, TT; Nguyen, T; Thanh Tran, T; Thanh Vo, TT; Thu Le, TT; Thu Nguyen, HT; Tran, HD; Tran, HG; Tuong Mai, V; Yong, N | 1 |
| Joerger, T; Swami, SK | 1 |
| Goldman, RD; Sih, K; Singla, S | 1 |
| Haverkate, MR; Marra, F; McCormack, J; Morris, AM; Patrick, DM; Povitz, M; Reid, JN; Saatchi, A; Shariff, SZ; Silverman, M | 1 |
| Genies, M; Gourishankar, A; Johnson, DP; Lee, V; Rajbhandari, P; Schefft, M | 1 |
| Adeleye, AI; Ajayi, A; Akinpelu, S; Smith, SI | 1 |
| Carciumaru, R; Crawford, T; Dalgleish, D; Fulford, M; Harman, S; Kam, AJ; Khan, S; Loeb, M; Main, C; Pernica, JM; Slinger, RS; Smieja, M; Thabane, L; Vanniyasingam, T | 1 |
| Barral, A; Fontoura, MH; Nascimento-Carvalho, CM; Puolakkainen, M; Ruuskanen, O; Vilas-Boas, AL; Xavier-Souza, G | 1 |
| Bobé, F; Carandell, E; Cortés, J; Cots, JM; García-Sangenís, A; Gestoso, S; Hernández, S; Llor, C; Llorente, M; Miravitlles, M; Morros, R; Pérez, A; Rezola, J; Román-Rodríguez, M | 1 |
| Bailey, J; Carciumaru, R; Fulford, M; Harman, S; Kam, A; Khan, S; Loeb, M; Main, C; Pernica, J; Slinger, R; Smieja, M; Thabane, L | 1 |
| Durrheim, D; Heller, J; Hughes, K; Jones, B; Massey, PD; Taylor, K | 1 |
| Edelstein, M; Kozhevin, R; Mayanskiy, N; Morrissey, I; Sidorenko, S; Torumkuney, D | 1 |
| Bratus, E; Dziublik, A; Liskova, A; Malynovska, K; Morrissey, I; Pertseva, T; Sopko, O; Torumkuney, D; Yachnyk, V | 1 |
| Bielicki, J; Fuchs, A; Mathur, S; Sharland, M; Van Den Anker, J | 1 |
| Boel, CHE; Bonten, MJM; Oosterheert, JJ; Postma, DF; Schweitzer, VA; Smits, RF; van Heijl, I; van Werkhoven, CH | 1 |
| Nascimento-Carvalho, AC; Nascimento-Carvalho, CM | 1 |
| Andrade, JV; Campos, J; Camurça, T; Vasconcelos, P | 1 |
| Barratt, S; Bielicki, JA; Dunn, D; Faust, SN; Finn, A; Gibb, DM; Harper, L; Hay, AD; Jackson, P; Little, P; Lyttle, MD; Powell, CVE; Robotham, J; Roland, D; Sharland, M; Stohr, W; Sturgeon, K; Wan, M | 1 |
| Chądzyńska, J; Czubik-Przybyła, A; Górska-Kot, A; Jackowska, T; Kraj, G; Krajewska, M; Krenke, K; Kulus, M; Mołdoch-Łukasik, A; Peradzyńska, J; Wołoszyn, K | 1 |
| Iroh Tam, PY | 1 |
| Kabra, SK; Lodha, R; Pandey, RM | 1 |
| Das, RR; Singh, M | 1 |
| Behere, S; Garber, MD | 1 |
| Gerber, JS; Hersh, AL; Kronman, MP; Localio, AR; Metjian, TA; Newland, JG; Ross, RK; Zaoutis, TE | 1 |
| Agweyu, A; Digolo, L; Kibore, M; Kosgei, C; Maina, V; Maleche-Obimbo, E; Mugane, S; Muma, S; Wachira, J; Waiyego, M | 1 |
| Averbuch, D; Blich, O; Breuer, O; Cohen-Cymberknoh, M; Kerem, E; Kharasch, S; Shoseyov, D | 1 |
| Morais, P; Pereira, A; Pinho, Â; Sousa, P | 1 |
| Billiemaz, A; Blanc, V; Chadapaud, S; Del Guidice, P; Dellamonica, J; Fribourg, A; Guardia, MD; Léotard, S; Mothes, A; Néri, D; Nicolle, I; Roger, PM; Smetz, A; Timontin, I; Toyer, AL; Vassallo, M | 1 |
| Das, MK; Ebels, K; Faulx, D; Gerth-Guyette, E; Ginsburg, AS; Mahapatro, S; Murunga, P | 1 |
| Andrade, DC; Nascimento-Carvalho, CM; Vilas-Boas, AL | 1 |
| Batard, E; Berrut, G; Chapelet, G; Corvec, S; de Decker, L; Herbreteau, G; Montassier, E | 1 |
| Adriaenssens, N; Bielicka, Z; Butler, CC; Coenen, S; Fernandez-Vandellos, P; Godycki-Cwirko, M; Goossens, H; Hupkova, H; Ieven, M; Kowalczyk, A; Lammens, C; Lannering, C; Little, P; Malhotra-Kumar, S; Mölstad, S; Parizel, M; Torres, A; Van Heirstraeten, L; Verheij, T | 1 |
| Kabra, SK; Lodha, R; Randev, S | 1 |
| Bijlsma, MW; Brouwer, MC; Costerus, JM; Tanck, MW; van de Beek, D; van der Ende, A | 1 |
| Carratalà, J; Dorca, J; Garcia-Vidal, C; Niubó, J; Simonetti, AF; Viasus, D | 1 |
| Biondi, E; Nazif, J; Nichols, E; Parikh, K; Ralston, S; Wasif, F; Williams, DJ | 1 |
| Anderson, P; Crengle Mahi, S; Farrell, E; Jansen, D; Kerdemilidis, M; Lennon, D; Percival, T; Stewart, J | 1 |
| Weiss, M | 1 |
| Gona, F; Marchese, G; Mezzatesta, ML; Nicoletti, G; Nicolosi, D; Stefani, S; Toscano, MA | 1 |
| Rapp, RP | 1 |
| Atkinson, M; Lakhanpaul, M; Lorgelly, PK; Smyth, AR; Stephenson, T; Vyas, H; Weston, V | 1 |
| Nascimento-Carvalho, CM | 1 |
| Bernardin, G; Cua, E; de Salvador, F; Dellamonica, J; Hyvernat, H; Landraud, L; Risso, K; Roger, PM; Vassallo, M | 1 |
| Andrade, SC; Araújo-Neto, CA; Barreto, BB; Brim, RV; Cardoso, MR; Fontoura, MS; Matutino, AR; Nascimento-Carvalho, CM; Noblat, L; Nobre-Bastos, M; Oliveira, F; Santana, MC; Santos, PM; Silva, CC | 1 |
| Hur, JK; Kang, JH; Kim, JH; Lee, KY; Lee, SY | 1 |
| Carbonnelle, S; De Bel, A; Dediste, A; Glupczynski, Y; Huang, TD; Jacobs, F; Jordens, P; Lismond, A; Schatt, P; Tulkens, PM; Van Bambeke, F; Verhaegen, J; Verschuren, F | 1 |
| Korppi, M | 1 |
| Bedos, JP; Billon, C; Le Bris-Tomczak, A; Le Monnier, A; Samdjee, F | 1 |
| Belabess, H; Honsali, Z; Jouhadi, Z; Lehlimi, M; Mdaghri, N; Najib, J; Sadiki, H; Zerouali, K | 1 |
| Duprat-Lomon, I; Lamping, DL; Marquis, P; Marrel, A; Sagnier, PP; Schroter, S | 1 |
| Cabré, X; Falguera, M; Ferrer, G; Pérez, J; Ruiz, A; Sacristán, O; Vallverdú, M | 1 |
| Hagberg, L; Leroy, B; Rangaraju, M; Ruuth, E; Torres, A; van Rensburg, D | 1 |
| Castro-Rodriguez, JA; Girardi, G; Kogan, R; Martínez, MA; Payá, E; Puppo, H; Quevedo, I; Rubilar, L | 1 |
| Corris, P; Duprat-Lomon, I; Höffken, G; Kubin, R; Muir, JF; Sagnier, PP; Torres, A | 1 |
| Absi, R; Arenoso, H; Bantar, C; Bustos, JL; Curcio, D; Franco, D; Izaguirre, M; Jasovich, A; Larrateguy, L; Mastruzzo, M; Mobilia, L; Morera, G; Oliva, ME; Prieto, S; Soutric, J; Vesco, E | 1 |
| Díaz de Tuesta Chow-Quan, AM; Dimas Nuñez, JF; Geijo Martínez, MP; Gómez Criado, C; Herranz, CR; Saiz García, F | 1 |
| Uno, Y | 1 |
| Iwata, T; Tajima, T | 1 |
| Carbon, C; Dunbar, L; Fogarty, C; Hagberg, L; Pullman, J; van Rensburg, DJ | 1 |
| de la Roza, C; Jardim, JR; Miravitlles, M; Obispo, E; Rico, G; Urueta, J; Wolff, M | 1 |
| Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
| Demartini, G; Esposti, D; Fraschini, F; Lapidari, A; Marthyn, P; Scaglione, F | 1 |
| Doherty, GM; Farrell, S; McCallion, WA; Milliken, I; Murphy, JL; Wootton, SA | 1 |
| Feldman, C; File, T; Léophonte, P | 1 |
| Sargeant, P | 1 |
| Bourdin, A; Génin, R; Lilienthal, F; Lugagne, N; Paganin, F; Tixier, F; Yvin, JL | 1 |
| Aurangzeb, B; Hameed, A | 1 |
| Arone, F; Bagetta, D; Bagetta, G; Florio, L; Lista, MR; Morrone, LA | 1 |
| Arbo, A; Lovera, D | 1 |
| Lee, WK; Young, BW | 1 |
| Toltzis, P | 1 |
| Díaz F, A; Pavié G, J; Prida C, JM; Saldías P, F | 1 |
| Allan, RC; Melzer, M; Moghal, M; Wijesuriya, V | 1 |
| Marre, R; Suttorp, N; Welte, T | 1 |
| Chisaka, N; Coovadia, HM; Fox, MP; Jeena, P; MacLeod, WB; Qazi, S; Thea, DM | 1 |
| Berti, I; Marchetti, F | 1 |
| Bonten, MJ; Bossuyt, PM; Bresser, P; de Borgie, CA; el Moussaoui, R; Hustinx, WN; Krouwels, FH; Opmeer, BC; Poley, JW; Prins, JM; Speelman, P; van den Berg, B; van den Berk, GE; van den Broek, P; Weenink, C | 1 |
| Bossuyt, PM; de Borgie, CA; El Moussaoui, R; Nieuwkerk, P; Opmeer, BC; Prins, JM; Speelman, P | 1 |
| Bonten, MJ; Buskens, E; Hoepelman, AI; Hustinx, WM; Kaasjager, K; Kramer, MH; Lammers, JW; Oosterheert, JJ; Prins, JM; Schneider, MM; Slee, PH | 1 |
| Pommer, P | 1 |
| Atkinson, M; Crane, J; Guntupalli, N; Halliday, K; Lakhanpaul, M; Morjaria, A; Ninan, T; Owen, V; Sammons, H; Sithole, J; Smyth, A; Stephenson, T; Vyas, H; Walton, L; Weston, V | 1 |
| Bassa, F; Coovadia, HM; Corr, P; Fox, M; Hamer, DH; Jeena, PM; McNally, LM; Minkara, AK; Thea, D | 1 |
| Decramer, M; Martin, M; Moore, L; Quilici, S; Simoens, S | 1 |
| Barcelona, L; Marín, M; Stamboulian, D | 1 |
| Dantes, RB; Roa, CC | 1 |
| Chan, R; Clancy, L; Feely, J; Hemeryck, L; O'Regan, M | 1 |
| Bru, JP; Gaillat, J; Sedallian, A | 1 |
| Maartens, G; Oliver, SP | 1 |
| Cooper, BC; Garrett, J; Karalus, NC; Lang, SD; Scott, HM; Scott, WG | 1 |
| Benard, Y; Boutin, C; Brambilla, C; Escamilla, R; Germaud, P; Guerin, JC; Jacqueme, P; Poirier, J; Zuck, P | 1 |
| Garau, J; Grassi, C; Hosie, J; Huchon, G; Legakis, N; Lode, H; Segev, S; Wijnands, G | 1 |
| Aubier, M; Gialdroni-Grassi, G; Hosie, J; Huchon, G; Legakis, N; Lode, H; Regamey, C; Segev, S; Tolstuchow, N; Vester, R; Wijnands, WJ | 1 |
| May, T; Portier, H; Proust, A | 1 |
| Chaussain, M; Gendrel, D; Iniguez, JL; Kalifa, G; Lebon, P; Moulin, F; Ravilly, S; Raymond, J; Truong, M | 1 |
| Felmingham, D; Grüneberg, RN | 1 |
| Berk, SL; Kalbfleisch, JH | 1 |
| Klugman, KP | 1 |
| Lee, SK; Ng, AW; Oh, HM | 1 |
| Gard, P; Guion, A; MacFarlane, JT; Prewitt, J | 1 |
| Jamil, B; Minai, AM; Mouton, SW; Sampers, GH; Smits, AJ; Sturm, AW; van der Pol, R; van Hellemondt, FM | 1 |
| Collins, JJ; Feris, J; Giguere, G; Hidalgo, H; Higuera, F | 1 |
| Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
| Gwaltney, JM; Keyserling, C; Leigh, A; Rivas, P; Savolainen, S; Scheld, WM; Schenk, P; Sydnor, A; Tack, KJ | 1 |
| Lim, TK | 1 |
| Dutchman, DA; Maroli, A; O'Doherty, B; Pettit, R | 1 |
| Aubier, M; Geslin, P; Regamey, C; Vercken, JB; Verster, R | 1 |
| Daniel, R; de Kock, F; Pluck, N; Trémolières, F | 1 |
| Léophonte, P | 1 |
| Poirier, R | 1 |
| Léophonte, P; Veyssier, P | 1 |
| Arenoso, HJ; Bantar, C; Blanco, M; Fernandez Canigia, L; Jasovich, A; Montoto, M; Nicola, F; Smayevsky, J; Soutric, J | 2 |
| Bisharat, N; Gilboa, A; Kennes, Y; Lavi, I; Okev, N; Raz, R | 1 |
| Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 1 |
| Arvis, P; Marel, M; Moita, J; Petitpretz, P; Urueta, J | 1 |
| Golledge, CL; Riley, TV | 1 |
| Carabias, ML; Cervera, LA; entelles, ML; García-Navas, BL | 1 |
| Chen, Y; Hao, F; Li, J; Zhang, Y | 1 |
| Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
15 review(s) available for amoxicillin and Community Acquired Infection
| Article | Year |
|---|---|
Decalogue for the selection of oral antibiotics for lower respiratory tract infections.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Community-Acquired Infections; Humans; Respiratory Tract Infections | 2022 |
Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Administration Schedule; Humans; Infant; Pneumonia | 2022 |
Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Guidelines as Topic; Humans; Infant; Infant, Newborn; Pneumonia, Bacterial; World Health Organization | 2018 |
Clinical management of community-acquired pneumonia in young children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Humans; Penicillins; Staphylococcus aureus | 2019 |
Approach to common bacterial infections: community-acquired pneumonia.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Diagnosis, Differential; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Medical History Taking; Physical Examination; Pneumonia, Bacterial; Pneumonia, Viral; Severity of Illness Index | 2013 |
Antibiotics for community-acquired pneumonia in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Chloramphenicol; Community-Acquired Infections; Drug Therapy, Combination; Gentamicins; Humans; Penicillins; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Developing Countries; Humans; Randomized Controlled Trials as Topic | 2013 |
An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Humans; Infant; Penicillins; Pneumonia; Randomized Controlled Trials as Topic | 2016 |
Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Humans; Infant; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Pharmacotherapy of childhood pneumonia.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Oxygen; Pneumonia; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2010 |
Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Ketolides; Macrolides; Naphthyridines; Penicillins; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
Comparison of amoxicillin with alternative agents for the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Child; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Otitis Media | 2005 |
[What is new in the treatment of community-acquired pneumonia?].
Topics: Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Therapy, Combination; Follow-Up Studies; Germany; Humans; Macrolides; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Time Factors | 2006 |
[Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sulbactam | 2008 |
The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Amoxicillin; Ampicillin; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Lactams; Moraxella catarrhalis; Neisseriaceae Infections; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumonia, Bacterial; Predictive Value of Tests; Streptococcus pneumoniae; Treatment Failure | 1996 |
48 trial(s) available for amoxicillin and Community Acquired Infection
| Article | Year |
|---|---|
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Duration of Therapy; Female; Humans; Infant; Male; Patient Discharge; Pneumonia; Retreatment; Severity of Illness Index | 2021 |
Five Days of Antibiotic Therapy Is Comparable with 10 Days in Children with Community-Acquired Pneumonia.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Humans; Infant; Ontario; Pneumonia; Treatment Outcome | 2021 |
Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi.
Topics: Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Female; Gastroenteritis; Humans; Infant; Malawi; Male; Pneumonia; Treatment Outcome | 2022 |
Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Community-Acquired Infections; Double-Blind Method; Humans; Infant; Pneumonia | 2022 |
Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Male; Pneumonia | 2021 |
Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin.
Topics: Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Chlamydia; Community-Acquired Infections; Female; Humans; Infant; Male; Mycoplasma; Pneumonia, Bacterial; Prospective Studies | 2017 |
Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Penicillin V; Pneumonia; Prospective Studies; Spain; Treatment Outcome | 2019 |
Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
Topics: Age Factors; Amoxicillin; Anti-Infective Agents; Antimicrobial Stewardship; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Equivalence Trials as Topic; Female; Humans; Male; Multicenter Studies as Topic; Ontario; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2018 |
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Dose-Response Relationship, Drug; Double-Blind Method; Duration of Therapy; Humans; Infant; Penicillin Resistance; Pneumonia; Retreatment | 2019 |
Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Community-Acquired Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Placebos; Pneumonia, Bacterial; Prospective Studies; Selection, Genetic; Streptococcal Infections; Streptococcus; Young Adult | 2016 |
Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis.
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Hospitalized; Child, Preschool; Community-Acquired Infections; Cost Savings; Health Care Costs; Health Expenditures; Humans; Infant; Infusions, Intravenous; Penicillin G; Pneumonia, Bacterial; State Medicine; United Kingdom | 2010 |
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Outcome Assessment, Health Care; Pneumonia, Bacterial; Psychometrics; Quality Assurance, Health Care; Quinolines; Surveys and Questionnaires | 2002 |
[Community-acquired pneumonia: usefulness of clinical presentation in the selection of antibiotic treatment].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Female; Hospitalization; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 2002 |
Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ketolides; Macrolides; Male; Middle Aged; Pneumonia, Bacterial | 2002 |
Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Topics: Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Humans; Infant; Male; Penicillins; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2003 |
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Penicillins; Pneumonia; Quinolines | 2003 |
Efficacy of amoxicillin-sulbactam, given twice-a-day, for the treatment of community-acquired pneumonia: a clinical trial based on a pharmacodynamic model.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sulbactam; Time Factors; Treatment Outcome | 2002 |
[Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
[Eradication of bacteria in upper pharynx of children treated with antibiotics].
Topics: Amoxicillin; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Penicillin Resistance; Pharyngitis; Pharynx; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Latin America; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Prospective Studies; Quinolines; Streptococcus pneumoniae; Treatment Outcome | 2003 |
Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-6; Male; Middle Aged; Penicillins; Pneumonia | 2004 |
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Urea | 2004 |
Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumonia, Pneumococcal; Treatment Outcome | 2004 |
Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Female; Humans; Infant; Length of Stay; Male; Pneumonia; Time Factors | 2003 |
Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Inpatients; Male; Pneumonia; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Sulbactam; Treatment Outcome | 2005 |
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Netherlands; Pneumonia, Bacterial; Treatment Outcome | 2006 |
Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Convalescence; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Quality of Life; Severity of Illness Index | 2006 |
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Combinations; Humans; Infusions, Intravenous; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2006 |
Pneumonia: 3 days of antibiotics for uncomplicated course.
Topics: Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Administration Schedule; Humans; Netherlands; Pneumonia; Severity of Illness Index; Treatment Outcome | 2006 |
Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Female; Humans; Infusions, Intravenous; Male; Penicillin G; Pneumonia, Bacterial; Treatment Outcome | 2007 |
Impact of HIV-1 status on the radiological presentation and clinical outcome of children with WHO defined community-acquired severe pneumonia.
Topics: AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Female; HIV-1; Humans; Infant; Lung; Male; Penicillins; Pneumonia; Prospective Studies; Radiography; Severity of Illness Index; Treatment Outcome; World Health Organization | 2007 |
Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
Topics: Adolescent; Adult; Amoxicillin; Bromhexine; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1995 |
Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community-Acquired Infections; Drug Costs; Drug Therapy, Combination; Female; Hospital Costs; Hospitals, General; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Respiratory Tract Infections; Sputum; Treatment Outcome | 1995 |
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Drug Tolerance; Erythromycin; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillin G; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Streptococcus pneumoniae; Treatment Outcome | 1994 |
Roxithromycin and lower respiratory tract infections.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community-Acquired Infections; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Humans; New Zealand; Respiratory Tract Infections; Roxithromycin | 1994 |
[Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases].
Topics: Adolescent; Adult; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Abscess; Male; Middle Aged; Prospective Studies | 1993 |
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Treatment Failure | 1995 |
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae | 1996 |
Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Pneumonia, Bacterial; Quinolones | 1996 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 1996 |
Comparison of amoxycillin and clarithromycin as initial treatment of community-acquired lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Penicillins; Respiratory Tract Infections; Single-Blind Method | 1996 |
Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome | 1996 |
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefdinir; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Single-Blind Method; Sinusitis; Treatment Outcome | 1997 |
Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Dropouts; Penicillins; Piperazines; Pneumonia, Bacterial; Quinolones; Treatment Outcome | 1997 |
Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Penicillins; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae | 1998 |
Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
[Levofloxacin in the treatment of community-acquired pneumococcal pneumonia].
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal | 1999 |
Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aza Compounds; Community-Acquired Infections; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Treatment Outcome | 2001 |
73 other study(ies) available for amoxicillin and Community Acquired Infection
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
In vitro activity of AR-709 against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia.
Topics: Adolescent; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Child, Preschool; Community-Acquired Infections; Critical Pathways; Drug Prescriptions; Drug Resistance, Microbial; Duration of Therapy; Emergency Service, Hospital; Female; Hospitalization; Humans; Infant; Italy; Macrolides; Male; Pneumonia; Treatment Outcome | 2021 |
Amoxicillin Dose and Duration of Treatment and Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia-Reply.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Duration of Therapy; Humans; Pneumonia | 2022 |
Amoxicillin Dose and Duration of Treatment and Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Duration of Therapy; Humans; Pneumonia | 2022 |
Risk of community- and hospital-acquired bacteremia and profile of antibiotic resistance in children hospitalized with severe acute malnutrition in Niger.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Child; Community-Acquired Infections; Drug Resistance, Microbial; Escherichia coli; Hospitals; Humans; Longitudinal Studies; Niger; Severe Acute Malnutrition | 2022 |
Amoxicillin for Children With CAP: Low-Dose for Three Days Is Noninferior to High-Dose for Seven Days.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Humans; Infant; Treatment Outcome | 2022 |
Pediatric Antibiotic Stewardship for Community-Acquired Pneumonia: A Pre-Post Intervention Study.
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Child; Community-Acquired Infections; Humans; Pneumonia | 2022 |
Community-acquired pneumonia-causing bacteria and antibiotic resistance rate among Vietnamese patients: A cross-sectional study.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Bacteria; Clavulanic Acid; Community-Acquired Infections; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Pneumonia, Pneumococcal | 2022 |
Evaluation of a 5-day High-Dose Course of Amoxicillin for the Management of Community-Acquired Pneumonia in Children of 6 months to 10 years of Age.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Humans; Infant; Pneumonia | 2022 |
Antibiotic treatment duration for community-acquired pneumonia in children.
Topics: Ambulatory Care Facilities; Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Duration of Therapy; Humans; Male; Pneumonia | 2023 |
Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care.
Topics: Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Prescriptions; Humans; Pneumonia; Practice Patterns, Physicians'; Retrospective Studies | 2023 |
Things We Do For No Reason™: Routine Blood Culture Acquisition for Children Hospitalized with Community-Acquired Pneumonia.
Topics: Amoxicillin; Ampicillin; Blood Culture; Child, Preschool; Community-Acquired Infections; Cough; Dyspnea; Fever; Hospitalization; Humans; Male; Pneumonia; Streptococcus pneumoniae; Vancomycin | 2020 |
Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cells, Cultured; Community-Acquired Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Imipenem; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Nigeria; Ofloxacin; Tertiary Care Centers | 2020 |
An atypical case of typical pneumonia
Topics: Adult; Amoxicillin; Animals; Birds; Community-Acquired Infections; Fever; Headache; Humans; Lethargy; Male; Pneumonia; Psittacosis; Radiography | 2018 |
Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Haemophilus Infections; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Middle Aged; Pneumococcal Infections; Respiratory Tract Infections; Russia; Streptococcus pneumoniae; Surveys and Questionnaires; Young Adult | 2018 |
Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Child; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Slovakia; Streptococcus pneumoniae; Surveys and Questionnaires; Ukraine; Young Adult | 2018 |
Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Healthcare-Associated Pneumonia; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Pneumonia, Bacterial | 2018 |
[Antibiotic Prescribing in Ambulatory Care of Pediatric Patients with Respiratory Infections].
Topics: Adolescent; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Bronchitis; Chi-Square Distribution; Child; Child, Preschool; Community-Acquired Infections; Female; General Practice; Humans; Infant; Infant, Newborn; Internship and Residency; Male; Otitis Media; Pediatrics; Pneumonia; Practice Patterns, Physicians'; Prospective Studies; Respiratory Tract Infections; Retrospective Studies; Streptococcus pyogenes; Tonsillitis | 2019 |
The Influence of National Guidelines on the Management of Community-Acquired Pneumonia in Children. Do Pediatricians Follow the Recommendations?
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Child; Community-Acquired Infections; Guideline Adherence; Hospitals; Humans; Pediatricians; Pneumonia; Practice Guidelines as Topic; Retrospective Studies | 2019 |
Community-acquired pneumonia: judicious use of antibiotics or treatment failure?
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteremia; Calcitonin; Child, Preschool; Community-Acquired Infections; Evidence-Based Medicine; Humans; Male; Pneumonia; Protein Precursors; Treatment Failure | 2013 |
Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children.
Topics: Adolescent; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Guideline Adherence; Hospitalization; Humans; Infant; Longitudinal Studies; Pediatrics; Pneumonia; Practice Guidelines as Topic; Societies, Medical; United States | 2014 |
Prevalence and correlates of treatment failure among Kenyan children hospitalised with severe community-acquired pneumonia: a prospective study of the clinical effectiveness of WHO pneumonia case management guidelines.
Topics: Amoxicillin; Anti-Bacterial Agents; Case Management; Child, Preschool; Community-Acquired Infections; Female; Guideline Adherence; Guidelines as Topic; Hospitalization; Humans; Infant; Kenya; Male; Pneumonia; Prevalence; Program Evaluation; Prospective Studies; Treatment Failure; World Health Organization | 2014 |
Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Ambulatory Care; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Community-Acquired Infections; Female; Fever; Hospitalization; Humans; Infant; Length of Stay; Linear Models; Logistic Models; Male; Multivariate Analysis; Penicillins; Pneumonia, Bacterial; Retrospective Studies | 2015 |
Acute onset of widespread pustular eruption.
Topics: Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Diagnosis, Differential; Drug Eruptions; Female; Humans; Pneumonia, Bacterial | 2015 |
Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Urine | 2015 |
Optimising adherence to childhood pneumonia treatment: the design and development of patient instructions and a job aid for amoxicillin dispersible tablets.
Topics: Amoxicillin; Anti-Bacterial Agents; Caregivers; Child; Communication; Community-Acquired Infections; Health Education; Health Personnel; Humans; India; Kenya; Medication Adherence; Pneumonia, Bacterial; Qualitative Research; Tablets | 2016 |
Rapid detection of amoxicillin-susceptible Escherichia coli in fresh uncultured urine: a new tool to limit the use of broad-spectrum empirical therapy of community-acquired pyelonephritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyelonephritis; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Time Factors | 2016 |
Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Brain; Cephalosporins; Community-Acquired Infections; Disease Management; Evidence-Based Medicine; Humans; Interrupted Time Series Analysis; Meningitis, Bacterial; Middle Aged; Netherlands; Practice Guidelines as Topic; Prospective Studies; Spinal Puncture; Tomography, X-Ray Computed; Young Adult | 2016 |
Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Penicillins; Pneumonia, Pneumococcal; Prospective Studies; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2017 |
A Multicenter Collaborative to Improve Care of Community Acquired Pneumonia in Hospitalized Children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asthma; Benchmarking; Child; Child, Preschool; Community-Acquired Infections; Cooperative Behavior; Drug Utilization; Emergency Service, Hospital; Hospitalization; Humans; Infant; Infant, Newborn; Macrolides; Pakistan; Penicillins; Pneumonia; Quality Improvement; United States | 2017 |
First Presentation Acute Rheumatic Fever is Preventable in a Community Setting: A School-based Intervention.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Cross-Sectional Studies; Humans; New Zealand; Pharynx; Primary Prevention; Rheumatic Fever; Schools; Streptococcal Infections; Streptococcus pyogenes; Students | 2017 |
[Risk assessment in community acquired pneumonia. Who should be hospitalized, who can be managed at home?].
Topics: Ambulatory Care; Amoxicillin; Calcitonin; Community-Acquired Infections; Decision Support Techniques; Drug Therapy, Combination; Hospitalization; Humans; Pneumonia, Pneumococcal; Protein Precursors; Radiography; Risk Assessment | 2008 |
Cefditoren versus community-acquired respiratory pathogens: time-kill studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2009 |
Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Doxycycline; Drug Resistance, Multiple, Bacterial; Humans; Kentucky; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Cohort Studies; Community-Acquired Infections; Comorbidity; Erythromycin; Female; France; Hospital Mortality; Hospitals, University; Humans; Legionella; Legionnaires' Disease; Lung Diseases, Fungal; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Rifampin; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2010 |
Clinical failure among children with nonsevere community-acquired pneumonia treated with amoxicillin.
Topics: Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Humans; Infant; Pneumonia, Bacterial; Treatment Outcome | 2010 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Korea; Respiratory Tract Infections; Streptococcus pneumoniae | 2010 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; beta-Lactams; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pneumonia, Pneumococcal; Quinolines; Streptococcus pneumoniae; Vaccination; Young Adult | 2012 |
Diagnosis and treatment of community-acquired pneumonia in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Finland; Humans; Lung; Penicillin G; Penicillin V; Pneumonia, Bacterial; Pneumonia, Viral; Practice Guidelines as Topic; Radiography | 2012 |
Antibiotic strategy in severe community-acquired pneumococcal pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Guideline Adherence; Hospitals, Municipal; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Retrospective Studies; Streptococcus pneumoniae; Young Adult | 2012 |
[Group A streptococcal meningitis].
Topics: Amoxicillin; Ampicillin; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Hospitals, University; Humans; Incidence; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Morocco; Postoperative Complications; Streptococcal Infections; Streptococcus pyogenes | 2012 |
[Therapy for children with acute pneumococcal otitis media in an outpatient clinic].
Topics: Acute Disease; Amoxicillin; Cephalosporins; Child, Preschool; Community-Acquired Infections; Humans; Infant; Middle Ear Ventilation; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Recurrence; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Community acquired pneumonia.
Topics: Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Doxycycline; Family Practice; Humans; Pneumonia; Practice Guidelines as Topic; Roxithromycin | 2004 |
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor.
Topics: Amoxicillin; Cephalosporins; Community-Acquired Infections; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Prognosis; Prospective Studies; Risk Factors; Streptococcus pneumoniae | 2004 |
Rational use of antibiotics in acute uncomplicated cystitis: a pharmaco-epidemiological study.
Topics: Acute Disease; Amoxicillin; Cohort Studies; Community-Acquired Infections; Cystitis; Drug Resistance, Bacterial; Female; Follow-Up Studies; Humans; Italy; Male; Microbial Sensitivity Tests; Pharmacoepidemiology; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
[Assessment of the management of community-acquired pneumonia in adults outpatients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Emergencies; Female; Frail Elderly; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies; Treatment Failure | 2005 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; Erythromycin; Humans; Male; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Students | 2006 |
Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia.
Topics: Amoxicillin; Child, Preschool; Community-Acquired Infections; Female; HIV Infections; Humans; Infant; Logistic Models; Male; Multicenter Studies as Topic; Penicillins; Pneumonia; Randomized Controlled Trials as Topic; South Africa; Treatment Failure; Zambia | 2006 |
Pneumonia: macrolides or amoxicillin for community acquired pneumonia?
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Community-Acquired Infections; Humans; Macrolides; Pneumococcal Infections; Pneumonia, Bacterial; Streptococcus pneumoniae | 2006 |
[Risk classification in community-acquired pneumonia].
Topics: Amoxicillin; Ampicillin; Community-Acquired Infections; Confusion; Humans; Patient Admission; Pneumonia, Bacterial; Risk Assessment; Severity of Illness Index | 2006 |
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; Cefuroxime; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Moxifloxacin; Pneumonia, Bacterial; Quinolines | 2008 |
Antibiotic resistance in community-acquired urinary tract infections.
Topics: Aged; Amoxicillin; Community-Acquired Infections; Drug Resistance, Microbial; Female; Humans; Male; Prevalence; Prospective Studies; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1994 |
[Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Humans; Infant; Penicillins; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Viral; Prospective Studies | 1996 |
A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project.
Topics: Amoxicillin; beta-Lactamases; Chloramphenicol Resistance; Community-Acquired Infections; Databases, Factual; Drug Resistance, Microbial; Europe; Haemophilus; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; United States | 1996 |
Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in western Europe and in the USA. The Alexander Project Collaborative Group.
Topics: 4-Quinolones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Europe; Humans; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; United States | 1996 |
Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ampicillin; Anti-Infective Agents; Community-Acquired Infections; Data Collection; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Middle Aged; Nonprescription Drugs; Pakistan; Respiratory Tract Infections; Self Medication | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Humans; Pneumonia, Bacterial | 1997 |
[Management of community-acquired pneumopathies of adults in the city and at the hospital].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Hospitalization; Humans; Penicillin G; Penicillin Resistance; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Radiography, Thoracic | 1998 |
[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Haemophilus influenzae; Humans; Penicillin Resistance; Penicillins; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Models, Biological; Moraxella catarrhalis; Neisseriaceae Infections; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Serum Bactericidal Test; Streptococcus pneumoniae; Sulbactam | 2000 |
Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bacteriuria; Cephalexin; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infant; Israel; Male; Middle Aged; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms.
Topics: Administration, Oral; Adult; Amoxicillin; Community-Acquired Infections; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Pneumonia, Bacterial; Serum Bactericidal Test; Streptococcus pneumoniae; Sulbactam | 2001 |
The efficacy of an antibiotic protocol for community-acquired pneumonia.
Topics: Amoxicillin; Australia; Azithromycin; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Drug Therapy, Combination; Drug Utilization; Humans; Pneumonia; Sensitivity and Specificity | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance; Fluoroquinolones; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Naphthyridines; Nasopharynx; Neisseria meningitidis; Respiratory Tract Infections; Rifampin; Time Factors | 2001 |
E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
Topics: Amoxicillin; Cefaclor; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |